Even established PAH therapies such as prostacyclins and sildenafil appear to potentiate the BMPR2 pathway somewhat, yet a direct comparison of their ability to increase BMP signaling has not been made [28,29]. Here, BMPR2 is linked to pulmonary arterial hypertension.